A New Small Molecule Inhibitor of Estrogen Receptor α Binding to Estrogen Response Elements Blocks Estrogen-dependent Growth of Cancer Cells*
暂无分享,去创建一个
Jingwei Cheng | E. Wilson | A. Nardulli | S. Nordeen | C. Mao | P. Hergenrother | D. J. Shapiro | M. Cherian | K. Putt | N. Patterson | Irene O Aninye | Chen Zhang | Jamie Bonéy Montoya | D. Shapiro | Irene O. Aninye | M. T. Cherian
[1] R. Clarke,et al. Progressive Loss of Estrogen Receptor α Cofactor Recruitment in Endocrine Resistance , 2007 .
[2] Jingwei Cheng,et al. Tamoxifen Induction of CCAAT Enhancer-binding Protein α Is Required for Tamoxifen-induced Apoptosis* , 2007, Journal of Biological Chemistry.
[3] Phuong Nguyen,et al. A surface on the androgen receptor that allosterically regulates coactivator binding , 2007, Proceedings of the National Academy of Sciences.
[4] E. Wilson,et al. Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone* , 2007, Journal of Biological Chemistry.
[5] John R Yates,et al. The deoxyribonucleic acid repair protein flap endonuclease-1 modulates estrogen-responsive gene expression. , 2007, Molecular endocrinology.
[6] H. Gabra,et al. Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor–Positive Patients , 2007, Clinical Cancer Research.
[7] D. J. Shapiro,et al. Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells , 2007, Oncogene.
[8] T. Richards. Access to health care in Afghanistan is improving, study shows , 2007, BMJ : British Medical Journal.
[9] S. Nordeen,et al. In Vitro Fluorescence Anisotropy Analysis of the Interaction of Full-length SRC1a with Estrogen Receptors α and β Supports an Active Displacement Model for Coregulator Utilization* , 2007, Journal of Biological Chemistry.
[10] A. Degterev,et al. Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G , 2007, Cell.
[11] Xinguo Jiang,et al. Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity. , 2007, Cellular immunology.
[12] E. Appella,et al. Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. , 2006, Cancer cell.
[13] P. Hergenrother,et al. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy , 2006, Nature chemical biology.
[14] J. Yates,et al. Protein Disulfide Isomerase Serves as a Molecular Chaperone to Maintain Estrogen Receptor α Structure and Function , 2006 .
[15] Myles A Brown,et al. Estrogen receptor target gene: an evolving concept. , 2006, Molecular endocrinology.
[16] Chin-Yo Lin,et al. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. , 2006, Cancer research.
[17] W. Gradishar,et al. Selective estrogen receptor modulators and prevention of invasive breast cancer. , 2006, JAMA.
[18] Paul J Hergenrother,et al. Obtaining and screening compound collections: a user's guide and a call to chemists. , 2006, Current opinion in chemical biology.
[19] C. Mao,et al. Analysis of RNA-protein interactions by a microplate-based fluorescence anisotropy assay. , 2006, Analytical biochemistry.
[20] D. Kranz,et al. Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells. , 2006, Endocrinology.
[21] K. Korach,et al. Estrogen receptors and human disease. , 2006, The Journal of clinical investigation.
[22] E. Alarid,et al. Altered Target Gene Regulation Controlled by Estrogen Receptor-α Concentration , 2006 .
[23] J. Yager,et al. Estrogen carcinogenesis in breast cancer. , 2006, The New England journal of medicine.
[24] R. Fletterick,et al. Discovery of Small Molecule Inhibitors of the Interaction of the Thyroid Hormone Receptor with Transcriptional Coregulators* , 2005, Journal of Biological Chemistry.
[25] V. Jordan,et al. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. , 2005, Mutation research.
[26] C. Gundy,et al. Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma , 2005, Clinical Cancer Research.
[27] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[28] D. Scudiero,et al. A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. , 2005, Analytical biochemistry.
[29] E. Winer. Optimizing endocrine therapy for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] R. Schiff,et al. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. , 2005, Clinical Cancer Research.
[31] S. Nordeen,et al. Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions. , 2004, BioTechniques.
[32] Mingsheng Zhang,et al. Ubistatins Inhibit Proteasome-Dependent Degradation by Binding the Ubiquitin Chain , 2004, Science.
[33] Xiaodong Wang,et al. A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death , 2004, Science.
[34] F. Boccardo. Switching trial of adjuvant tamoxifen with an aromatase inhibitor in postmenopausal patients with breast cancer. , 2004, Clinical breast cancer.
[35] L Earl Gray,et al. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[36] Martin C Frith,et al. Genomic targets of nuclear estrogen receptors. , 2004, Molecular endocrinology.
[37] D. Livingston,et al. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. , 2004, Cancer cell.
[38] D. Edwards,et al. Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. , 2004, Essays in biochemistry.
[39] Michelle R. Arkin,et al. Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.
[40] P. Hergenrother,et al. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors. , 2004, Analytical biochemistry.
[41] A. Krieg,et al. Interplay between Estrogen Response Element Sequence and Ligands Controls in Vivo Binding of Estrogen Receptor to Regulated Genes* , 2004, Journal of Biological Chemistry.
[42] Ping Zhang,et al. Increases in estrogen receptor‐α concentration in breast cancer cells promote serine 118/104/106‐independent AF‐1 transactivation and growth in the absence of estrogen , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] B. Katzenellenbogen,et al. Antiestrogens: Mechanisms of action and resistance in breast cancer , 1997, Breast Cancer Research and Treatment.
[44] E. Appella,et al. Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor , 2004, Nature Medicine.
[45] Minetta C. Liu,et al. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling , 2003, Oncogene.
[46] Mitch Dowsett,et al. Aromatase inhibitors in breast cancer. , 2003, The New England journal of medicine.
[47] C. Meijer,et al. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. , 2002, Blood.
[48] V. Jordan. The Past, Present, and Future of Selective Estrogen Receptor Modulation , 2001, Annals of the New York Academy of Sciences.
[49] A. Krieg,et al. A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1). , 2001, Molecular endocrinology.
[50] C. Klinge. Estrogen receptor interaction with estrogen response elements. , 2001, Nucleic acids research.
[51] D. Edwards,et al. Expression and purification of recombinant human progesterone receptor in baculovirus and bacterial systems. , 2001, Methods in molecular biology.
[52] Myles Brown,et al. Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.
[53] B. Katzenellenbogen. Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways. , 2000 .
[54] R. Offringa,et al. Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein , 1999, The Journal of experimental medicine.
[55] Thomas D. Y. Chung,et al. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.
[56] M. S. Ozers,et al. Equilibrium Binding of Estrogen Receptor with DNA Using Fluorescence Anisotropy* , 1997, The Journal of Biological Chemistry.
[57] K. Glenn,et al. Analysis of ligand dependence and hormone response element synergy in transcription by estrogen receptor , 1997, The Journal of Steroid Biochemistry and Molecular Biology.
[58] J. Barrett,et al. BG-1 ovarian cell line: An alternative model for examining estrogen-dependent growth in vitro , 1998, In Vitro Cellular & Developmental Biology - Animal.
[59] D. Edwards,et al. A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. , 1989, Molecular endocrinology.
[60] K. Hagino-Yamagishi,et al. [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.
[61] A. J. Dietz,et al. The synthesis and pharmacologic evaluation of a series of 8-alkylthio-thiated theophyllines. , 1966, Journal of medicinal chemistry.
[62] A. J. Dietz,et al. The synthesis of some 8-alkylthio-2-thiotheophyllines and 8-alkylthio-6-thiotheophyllines. , 1966, Journal of medicinal chemistry.
[63] A. Chadli. THE CANCER CELL , 1924, La Presse medicale.